
Meeting report: summary of Day 3 of the 2021 ISMPP Annual Meeting
Missed the meeting? Read our report to get up to speed!
A central online news resource for professionals involved in the development of medical publications and involved in publication planning and medical writing.
Missed the meeting? Read our report to get up to speed!
It is standard practice to name professional medical writers in publications, but how should we acknowledge subcontracted or freelance support?
Find out more about how disproportionate care loads, exacerbated by the pandemic, are impacting women’s ability to participate in scientific publishing.
Two articles explore how the use of metrics has enabled the evolution of new types of scientific fraud, including citation manipulation.
Get up to date with the key improvements in research recognition, including information on contributor roles taxonomy (CRediT) and updates to ORCID.
ISMPP poll result in ‘The MAP’ explores what to do if you have concerns about a potentially insufficient manuscript review by non-English speaking authors
A survey provides insights into the effects of COVID-19 on medical communications and the immediate and long-term adjustments being made as a result.
Part B of a two-part series delves into the practicalities of patient authorship and offers tips for effective and ethical patient collaboration.
Patient authorship is here and here to stay. Part A of a two-part series explores how sponsors may benefit from patient authorship, or risk getting left behind.
Find out more about how medical publication professionals make decisions about authorship order.
Find out more about ISMPP’s guidance for navigating author non-responsiveness in the wake of the coronavirus pandemic.
Listen to patient partnership specialist Lauri Arnstein’s perspectives on the role of patients in medical publishing.
Jackie Marchington gives her perspective on the Good Practice for Conference Abstracts and Presentations (GPCAP) recommendations.
Dawn Lobban, Senior Scientific Lead at Alligent Europe, Envision Pharma shares her experience of involving patients in medical publishing.
A new poll result published in the MAP newsletter explores the best approach for dealing with a non-responsive lead author.
The MAP newsletter explores an issue faced by medical publication professionals.